[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review

October 2019 | 58 pages | ID: ACE110A2313EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aspen Pharmacare Holdings Ltd (Aspen) is a provider of specialty and generic pharmaceuticals for the treatment of a range of acute and chronic conditions. The company focuses on thrombosis, anesthetics and high potency and cytotoxics therapeutic categories. Its manufacturing capabilities cover a range of product-types including oral solid dose, semi-solids, liquids, steriles, biological, and active pharmaceutical ingredients (APIs). The company has presence in Sub-Saharan Africa, Latin America, South East Asia, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.

Aspen Pharmacare Holdings Ltd Key Recent Developments

Sep 16,2019: Aspen Pharmacare Holdings: Appointment of Ben Kruger as Lead independent Non-Executive Director
Sep 11,2019: Aspen generates strong second half cash flows, reducing borrowings
Aug 14,2019: Aspen Pharmacare Holdings - Settlement discussion in respect of The UK competition authority investigation
Jun 18,2019: Aspen opens anaesthetic building as part of €100 million investment at its French-based site
Mar 25,2019: Aspen approved for secondary listing on A2X

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Aspen Pharmacare Holdings Ltd - Key Facts
Aspen Pharmacare Holdings Ltd - Key Employees
Aspen Pharmacare Holdings Ltd - Key Employee Biographies
Aspen Pharmacare Holdings Ltd - Major Products and Services
Aspen Pharmacare Holdings Ltd - History
Aspen Pharmacare Holdings Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Aspen Pharmacare Holdings Ltd - Business Description
Business Segment: Commercial Pharma
Overview
Performance
Business Segment: Manufacturing
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Developed Europe
Performance
Geographical Segment: Developing Europe and CIS
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: MENA
Performance
Geographical Segment: Sub-Saharan Africa
Performance
Geographical Segment: The US & Canada
Performance
Aspen Pharmacare Holdings Ltd - Corporate Strategy
Aspen Pharmacare Holdings Ltd - SWOT Analysis
SWOT Analysis - Overview
Aspen Pharmacare Holdings Ltd - Strengths
Aspen Pharmacare Holdings Ltd - Weaknesses
Aspen Pharmacare Holdings Ltd - Opportunities
Aspen Pharmacare Holdings Ltd - Threats
Aspen Pharmacare Holdings Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Aspen Pharmacare Holdings Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 16, 2019: Aspen Pharmacare Holdings: Appointment of Ben Kruger as Lead independent Non-Executive Director
Sep 11, 2019: Aspen generates strong second half cash flows, reducing borrowings
Aug 14, 2019: Aspen Pharmacare Holdings - Settlement discussion in respect of The UK competition authority investigation
Jun 18, 2019: Aspen opens anaesthetic building as part of €100 million investment at its French-based site
Mar 25, 2019: Aspen approved for secondary listing on A2X
Mar 18, 2019: Two-drug combos using popular calcium channel blocker show superiority in lowering blood pressure
Mar 08, 2019: Aspen’s encouraging emerging market growth
Nov 14, 2018: Aspen Invests $0.24B in its Port Elizabeth, South Africa Site to Manufacture Sterile Anesthetics
Oct 26, 2018: Aspen's participation in the 2018 Investment Conference
Sep 13, 2018: Aspen’s revenue increases to R42.6 billion and it reaches agreement on the divestment of its Nutritionals Business

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Aspen Pharmacare Holdings Ltd, Key Facts
Aspen Pharmacare Holdings Ltd, Key Employees
Aspen Pharmacare Holdings Ltd, Key Employee Biographies
Aspen Pharmacare Holdings Ltd, Major Products and Services
Aspen Pharmacare Holdings Ltd, History
Aspen Pharmacare Holdings Ltd, Other Locations
Aspen Pharmacare Holdings Ltd, Subsidiaries
Aspen Pharmacare Holdings Ltd, Joint Venture
Aspen Pharmacare Holdings Ltd, Key Competitors
Aspen Pharmacare Holdings Ltd, Annual Ratios
Aspen Pharmacare Holdings Ltd, Annual Ratios (Cont...1)
Aspen Pharmacare Holdings Ltd, Annual Ratios (Cont...2)
Aspen Pharmacare Holdings Ltd, Interim Ratios
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Aspen Pharmacare Holdings Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Aspen Pharmacare Holdings Ltd, Performance Chart (2015 - 2019)
Aspen Pharmacare Holdings Ltd, Ratio Charts
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Novartis AG
Baxter International Inc
AstraZeneca Plc
Ascendis Health Ltd
Pfizer Inc
Merck & Co Inc
Adcock Ingram Holdings Ltd


More Publications